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ABSTRACT
In all organisms, genes exist that encode for regulatory proteins, called
transcription factors (TFs), that can activate or repress transcription of specific genes
depending on their biological function. Thermus thermophilus HB8 is speculated to
contain 2,245 genes, of which 70 are postulated to be transcription factors. However, but
for very few, little is known regarding the genes they regulate and their biological
functions. The novel combinatorial method Restriction Endonuclease Protection,
Selection, and Amplification (REPSA) has successfully identified and validated
consensus binding sequences in T. thermophilus HB8 with previously studied TFs. Here
REPSA was explored as a technique and method for characterizing TTHA1437 and
TTHA1719 TFs in T. thermophilus HB8. TTHA1437 REPSA results showed a promising
DNA selection, but the results were not reproducible. Contrarily, TTHA1719 REPSA
results did not show any selected DNAs, but during REPSA selections, a rare DNA
species, the asterisk species, was observed. REPA results for TTHA1437 showed
nonspecific binding, and TTHA1719 results showed no validation. EMSA also exhibited
no DNA-ligand complex formation for both TFs. From the literature, a proposed potential
consensus DNA for TTHA1719 proved promising with initial REPAs, and possible
homologous DNA-binding consensus sequences for TTHA1437 and E. coli CRP were
explored. Unfortunately, these were ultimately unsuccessful. These results demonstrate
that REPSA is not a viable method to characterize all TFs and prompted us to explore
why REPSA does not work for these T. thermophilus HB8 TFs and how it could be
ii

improved. One possible improvement could entail more extensive preliminary DNAbinding assays with potential DNA-binding site(s) before embarking on REPSA
selections.
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INTRODUCTION
Chapter 1.1 Bacterial Transcription Factors
The vast amount of sequence data presently available on whole genomes
(eukaryotic and prokaryotic) is staggering since the Human Genome Project (HGP) was
completed in 2003, the price of sequencing technologies has significantly decreased thus
allowing for affordable in-house Next Generation Sequencing (NGS).1 Although many
genomics, transcriptomics, and metabolomics data have been obtained since the
completion of the HGP, the biological functions of many genes are still unknown and
therefore are unable to be assigned. Thus, scientists turn to one of the simpler organisms
in life, prokaryotes.2 Despite the fact that eukaryotic organisms are genetically more
diverse than prokaryotic organisms, there are in fact prokaryotes which are model
organisms for understanding the biological functionsof genes, as well as gene
regulation.3,4 Some well-known model prokaryotes include Escherichia coli (E. coli),
Pseudomonas aeruginosa (P. aeruginosa), and Thermus thermophilus (T. thermophilus).5
An extremely important cellular process throughout all organisms of life,
transcription, converts the information encoded in the genome (DNA) to messenger RNA
(mRNA), transfer RNA (tRNA), or ribosomal RNA (rRNA)6. The central dogma of
molecular biology describes the flow of genetic information, DNA→RNA→protein.
Without gene expression, cells would be unable to express proteins and therefore unable
to perform even basic cellular functions. The transcription process is highly regulated, in
part by proteins called transcription factors (TFs).7 Without control by TFs there would
be unnecessary transcripts being transcribed and necessary transcripts not being
1

transcribed, both outcomes are detrimental. TFs are an organism’s key to gene
regulation; either activating or repressing genes of interest during the initiation of
transcription.8 Transcription factors regulate gene expression by interacting with
promoter and/or enhancer elements upstream of the transcriptional startsite. When they
interact with these regulatory elements the gene of interest can be repressed or
activated.8,9 Transcriptional repressors block RNA Polymerase (RNAP) holoenzyme
from binding promoter DNA, and therefore repressing transcription. In contrast,
transcriptional activators recruit RNAP holoenzyme which then increases the frequency
of transcription.10,11 Although many TFs have been identified and characterized in E. coli
and P. aeruginosa, there is a lack of knowledge in the extreme thermophile, T.
thermophilus.
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Chapter 1.2 Types of Transcriptional Regulators
A classic and extremely well characterized model for gene regulation is the lac
operon in Escherichia coli which is involved in lactose metabolism.12 The lac operon
contains a single promoter region and consists of three structural genes denoted lacZ,
lacY, and lacA which encode for β-galactosidase, galactoside permease, and galactoside
acetyltransferase respectively. Although these genes are regulated in parallel, galactoside
acetyltransferase does not play a major role in lactose metabolism.12 Upstream of the
structural genes, there exists a catabolite activator protein (CAP) binding site, a promoter,
and an operator region which are involved in the regulation of the lac operon; therefore,
transcription can be activated or repressed.
Transcription is initiated at the promoter site which is located just upstream of the
structural gene lacZ. In the event that cellular concentrations of glucose are high and that
lactose is unavailable, a repressor protein will bind to the operator region and the lac
genes will not be expressed.12,13 Contrarily, positive transcription control will occur if the
cellular concentration of glucose is low and lactose is high. When glucose levels are low,
levels of cAMP are high and readily bind with the catabolite activator protein (CAP).13
Once the CAP-cAMP complex is formed, the transcriptional activator binds DNA within
the promoter region and allows robust expression of the lac genes. The positive and
negative regulation of the lac operon is extremely important for cells to adequately
respond to environmental changes and stressors.14,15
CRPs, also known as catabolite activator proteins (CAPs), tend to be homologous
throughout many organisms due to their similar amino acid residues, structural similarity,
and helix-turn-helix (HTH) motifs.16 The HTH motif, two α-helices joined by a short
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loop of amino acids, is extremely important for DNA-binding proteins, especially
transcription factors.17 Many HTH proteins bind to DNA in a dimer fashion and
recognize palindromic sequences as their DNA-binding domain (DBD).17,18 Similarly,
other DNA-binding proteins (e.g. restriction endonucleases), recognize palindromic DNA
sequences, which is important for their cleavage specificity. Although there are proteins
that recognize non-palindromic sequences, the majority of regulatory proteins prefer
palindromic sequences such as the CRP global regulator in E. coli.19
In Escherichia coli there exists a set of transcription factors which are involved in
the regulation of multiple genes when a cellular stress-response is activated. Interestingly,
one of these TFs is the E. coli cAMP receptor protein (CRP); this CRP is a global
regulator within E. coli due to the sheer number of genes this transcription factor
regulates.19,21 One unique property of E. coli CRP is its ability to act as an activator,
repressor, coactivator and corepressor. This unique property, along with the different
classes of promoters it recognizes, permits CRP to regulate a tremendous amount of
Escherichia coli’s genome.21 Although it only directly regulates the transcription of ~300
of the ~4500 genes (depending on the strain), the E. coli CRP indirectly regulates gene
expression of about half the genome.22
Global regulators and local regulators are defined by the number and the function
of the genes they regulate. Global TFs regulate many operons with different metabolic
functions, while local TFs regulate single gene pathways or operons which belong to the
same functional classification. Interestingly, global regulators can interact with local
regulators to form a co-regulation mechanism which can in turn lead to a feedback loop
which can widely influence gene expression22. Although a vast amount of information is
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known about the Escherichia coli CRP global gene regulator, there is very little
knowledge available about the homologous Thermus thermophilus CRP, TTHA1437.

5

Chapter 1.3 Identification and Characterization of TFs in Thermus thermophilus HB8
In the past, the Van Dyke laboratory has used REPSA to identify
transcriptional regulators in the extreme thermophile and model organism Thermus
thermophilus HB8. This gram-negative, rod shaped, aerobic bacterium was first isolated
from a Japanese hot spring in 1968 and can grow in temperatures ranging from 50°C to
82°C, with its optimal growth temperature being between 65°C and 72°C.23,24 Although
there are two well-studied strains of T. thermophilus, HB8 and HB27, our focus is on the
HB8 strain given that it is the model organism for the Structural-Biological Whole Cell
Project at the RIKEN Institute in Japan.25 The Whole Cell Project aims to understand all
biological phenomena within T. thermophilus HB8 at an atomic level through the
determination of three-dimensional structures for all of its proteins. To date, the
Structural-Biological Whole Cell Project has purified 944 T. thermophilus HB8 proteins
and 682 of these have been crystallized.25
The genome of the HB8 strain consists of a ~1.85 Mbp circular chromosome
(TTHA), a mega plasmid of ~0.26 Mbp (TTHB), and a mini plasmid of ~9.3 kbp
(TTHC).25 The difference between the genome of HB8 and HB27 is that HB8 has the
addition of the mini plasmid, TTHC, which gives the HB8 strain a unique advantage as a
facultative anaerobe versus an obligate anaerobe (HB27). The transcription factors of
interest for this study are located on the circular chromosome and denoted TTHA1437
and TTHA1719. TTHA1437 is 23,819 Daltons (Da) in mass and is suspected to belong to
the CRP family of activators in T. thermophilus HB8 including TTHA1437, TTHA1567
and TTHB099 due to their homology within the E. coli CRP global regulator.20,26,27
TTHA1719 is a transcriptional repressor with a mass of 10,858 Da and is suspected to be
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a copper homeostasis operon regulatory protein due to its homology with CsoR from M.
tuberculosis and B. subtilis.28
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Chapter 1.4 Significance of Restriction Endonuclease Protection, Selection, and
Amplification for Identifying Preferred DNA-Binding Sites
Restriction Endonuclease Protection, Selection, and Amplification (REPSA) is a
novel combinatorial method developed by the Van Dyke laboratory. This is an in vitro
PCR-based technique that utilizes a pool of randomized DNA sequences to select for TFDNA interactions. When a type IIS restriction endonuclease (IISRE) is introduced, any
uncomplexed DNAs will be cleaved and intact templates will be PCR amplified to
further select for a DNA-binding sequence. One of the key components of the REPSA
selection method is the DNA selection template which is derived from the ST2R24 or
ST2R35 template precursors (Figure 1A and 1B). Both selection templates are composed
of a 23-mer (ST2L) primer on the 5’ end and a fluorescently red-labeled 25-mer
(IRD7_ST2R) primer on the 3’; both primers flank the internal randomized region (either
24-mer or 35-mer, respectively). The IRD7_ST2R primer was specifically designed to
contain the binding/recognition sites for two differenttype IIS restriction endonucleases:
FokI (CATCC) and BpmI (CTCCAG).29

Figure 1A. REPSA selection templates ST2R24 and ST2R35. A
depiction of the ST2R24 REPSA selection template and its components
(ST2R35 not pictured). ST2L and IRD7_ST2R primers are denoted by
horizontal arrows, (N) denotes random nucleotides within the
randomized region (only difference between ST2R24 and ST2R35 are
N=24 or N=35), and the brackets and small arrows denote the
recognition domain and cleavage domain of IISREs FokI and BpmI.
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Type IISREs are unique compared to other restriction endonucleases since they
bind asymmetric dsDNA at a specific sequence (recognition domain) but cleave at a
fixed distance away (cleavage domain); this distance varies for different IISREs. These
types of restriction endonucleases are useful for many applications in molecular biology
such as gene cloning and DNA fragmentation.30 IISREs also allow theprobing of a
randomized region to select for sequences that specifically bind a DNA- binding ligand
(e.g., transcription factor). This unique characteristic allows REPSA selections to work
for a variety of different DNA-binding molecules (e.g. drugs, multiplex DNAs,
proteins).31
The novel combinatorial method Restriction Endonuclease, Protection, Selection,
and Amplification (REPSA) is a PCR-based method used to identify and characterize
nucleic acid-protein interactions. REPSA experiments utilize the ST2R24 DNA selection
template, IISREs, and a ligand of interest; in our case TTHA147.29 A schematic for
REPSA selection is shown in Figure 2. Here, the black regions represent the known
flanking regions of the template while the red region represents the internal randomized
region.29,32,33 Once the ligand is introduced (green) it will bind to any preferred
sequences that are present in the DNA pool. Due to the varying templates in the
selection pool, the ligand will initially have very few templates to bind to. Thus, this
selection method requires multiple rounds to identify a preferred DNA-binding site.
Once the ligand has been introduced to the selection templates, a IISRE is then
introduced and any template with a ligand bound will not be cleaved, yet all unbound
templates will be cleaved. An aliquot of the experimental reaction (DNA+IISRE+ligand)
is then subjected to polymerase chain reaction (PCR), amplifying the selection templates
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in 6, 9, and 12 cycles. The PCR reaction will not amplify any DNAs that have been
cleaved, thus selecting for protected templates.29
During a round of REPSA, there are three reactions that run in parallel. The first
being a control: DNA template, no IISRE, and no ligand (-/-). The second reaction is also
a control, but a cleavage control: DNA template, IISRE, and no ligand (-/+). The third
and most important reaction is the binding reaction: DNA template, IISRE, and
TTHA1437. These reactions and the subsequent PCRs are visualized using 10% native
PAGE and IR fluorescence to determine how much selection has occurred. The dsDNA
concentration of the DNA pool is also quantified using a Qubit assay. Sequential rounds
of REPSA are performed until ~50% cleavage inhibition is finally observed.
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Figure 2. The REPSA method. A diagram depiction of restriction endonuclease
protection, selection, and amplification (REPSA) and all the components included.
The DNA selection template pool is symbolized by the black (primers) and red (24or 35-mer randomized region). The ligand (TTHA1437 or TTHA1719) is shown in
green, and the IISRE is shown in brown. The first step is the introduction of the
ligand to the template pool at which time only a small percentage of DNAs will be
bound to the ligand (complex formation step). The second step introduced a IISRE
(either FokI or BpmI) which will cleave all DNA templates that are unbound by the
ligand. After, this reaction will be subjected to PCR amplification but only the
protected DNA species will amplify which further selects for the preferred DNAbinding sequence. Finally, the amplified DNAs will be used as the input for the next
round of REPSA; subsequent rounds of REPSA will typically result in a selected
DNA sequence which is ligand specific.
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In Figure 3, rounds 1 and 7 of REPSA selections are shown for another T.
thermophilus transcriptional regulator, SbtR, that has been previously studied.32 Due to
self-inhibitory cleavage by certain IISREs, the restriction endonuclease was switched
from FokI to BpmI between rounds 4 and 5. In round 7, ~50% cleavage resistance due to
sequence selection occurred, thus validating that this selection method is feasible, so the
same experimental approach was to be used to identify and characterize TTHA1437 and
TTHA1719.

Figure 3. Expected REPSA results. Shown are IR fluorescence images of restriction
endonuclease cleavage-protection assays for Round 1 and Round 7 of REPSA
selections with SbtR protein. Reactions in lane 1 represents the DNA control (+/-),
lane 2 being the cleavage control containing the DNA template and IISRE (-/F or -/B
to represent FokI and BpmI IISREs respectively), and lane 3 is the experimental
reaction containing DNA template, IISRE, and SbtR (+/F or +/B). Band designations:
(T) intact ST2R24 selection template, (X) cleaved ST2R24 selection template, and (P)
IRD7_ST2R primer. This image has been adapted from Figure 4 in Reference 32.
Once a pool of protected DNA templates has been selected, it is important to
validate that the selection contains bona fide DNA-binding sites. It is important to
validate the experimental results before sequencing due to the occurrence of non-specific
binding artifacts. One validation experiment is Restriction Endonuclease Protection
12

Assay (REPA) which is similar to REPSA but, does not include the amplification step.
An example is shown in Figure 4A for the previously studied SbtR.32 REPA validations
require a known DNA control (REPSAis) and the experimental REPSA DNA. Since
TTHA1437 requires the effector molecule 3’,5’-cyclic adenosine monophosphate
(cAMP), REPA will be the preferred method for validating the selection. Another
validation experiment is Electrophoretic Mobility Shift Assay (EMSA), also called a gel
shift assay, which is an extremely common technique used to determine nucleic acidprotein interactions (Figure 4B).33,34 Although EMSA is an important nucleic acid-ligand
assay, if the protein of interest requires an effector molecule it is not the most effective
method to validate a REPSA selection. Both REPA and EMSA methods should be viable
to validate TTHA1719 REPSA-selected DNAs since it is not known to require an
effector molecule to repress transcription.28

Figure 4. Traditional methods used to validate REPSA results. (A) Shown are LICOR
images of IRD7-labeled SbtR consensus DNA (red) and IRD8-labeled REPSAis control
DNA (green) subjected to BpmI cleavage following binding reactions in the presence of
(left to right) 0, 1, 10, 100, 1000 nM dimer SbtR protein. (C) Uncleaved DNA control
lane. (T) intact, uncleaved DNA, (X) cleaved DNA. (B) Shown are LICOR images of
EMSAs containing pooled DNA from either Round 1 (left lanes) orRound 5 (right
lanes) of REPSA selection and increasing concentrations of FadR protein (from left to
right: 0, 0.6, 6, 60, or 600 nM FadR). The electrophoretic mobility of a single proteinDNA complex (S) as well as uncomplexed ST2R24 selection template (T) and
IRD7_ST2R primer (P) are indicated at right of figure. These figures have been adapted
from Figures 7 and Figure 2 from References 32 and 33 respectively.
13

Chapter 1.5 Investigation of Known and Proposed Consensus DNAs
For both T. thermophilus HB8 transcription factors in these studies, TTHA1437
and TTHA1719, there have been proposed potential consensus DNAs for their DNAbinding sites.26,28 One of the problems that arises from these proposed consensus DNAs is
that little, if any, binding assays were performed with their proposed consensus
sequence(s). Although bioinformatic approaches can be extremely useful for determining
possible ligand-nucleic acid analyses, it is important to test the findings of these
bioinformatic studies to determine if it is in fact a true DNA-binding site. In order to
validate these findings, it was important for us to investigate these proposed consensus
sequences via different binding assays (REPA and EMSA). Furthermore, the DNAbinding consensus sequence for E. coli CRP was of interest in this study since
TTHA1437 is a supposed homolog and belonging to the CRP/FNR group in T.
thermophilus. The E. coli CRP consensus DNA-TTHA1437 interactions were to be
investigated using EMSA and BLI.22 The sequences of these known and proposed
consensus DNAs can be found in Table 1.

14

Chapter 1.6 Hypothesis and Specific Aims
A reverse genetic approach can be used to identify and characterize T.
thermophilus HB8 transcriptional regulators TTHA1437 and TTHA1719 and possible
ascertain their biological functions.
1. Express and purify the proteins of interest, TTHA1437 and TTHA1719.
2. Use Restriction Endonuclease Protection, Selection, and Amplification (REPSA)
to identify preferred DNA-binding sequences for TTHA1437 and TTHA1719.
3. Validate the REPSA selections via REPA, EMSA, and BLI.
4. Perform binding assays (REPA, EMSA, BLI) with proposed potential consensus
DNAs and known consensus DNAs.
5. Analyses of results and bioinformatic studies, if REPSA-selected DNAs are
validated, to determine the possible biological function of TTHA1437 and
TTHA1719.

15

MATERIALS AND METHODS
Chapter 2.1 Oligonucleotides and Selection Template Preparation
The oligonucleotide precursors and primers used in these studies were synthesized
and purified by Integrated DNA Technologies and are listed in Table 1. Two different
selection templates, ST2R24 and ST2R35, were PCR amplified to create double-stranded
DNA libraries for both templates. Each template was designed so the randomized cassette
regions have an average nucleotide composition of 25% A, 25% T, 25% C, and 25% G at
each position. Preparation of the ST2R24 template involved five 25 µL reactions in
which each contained 1 ng single-stranded ST2R24 precursor DNAs, 1X Standard Taq
Reaction Buffer (New England Biolabs, NEB), 560 nM ST2L primer, 560 nM
IRD7_ST2R primer, 50 µM dNTPs, and 25 U Taq DNA Polymerase. These reactions
were PCR amplified with the cycling conditions comprising of 5 cycles of 95°C for 30
sec, 60°C for 30 sec, and 68°C for 1 min; 1 cycle of 95°C for 30 sec, 60°C for 30 sec, and
68°C for 1.5 min; the final cycle of 95°C for 30 sec, 60°C for 30 sec, and 68°C for 2 min.
The ST2R35 template was prepared in a similar manner to ST2R24 although the
reaction and cycling conditions differed slightly. Preparation of ST2R35 comprised of
three 25 µL reactions with each containing 1 ng single-stranded ST2R35 precursor
DNAs, 1X Standard Taq Reaction Buffer (NEB), 200 nM ST2Ls primer, 200 nM
IRD7_ST2R primer, 200 µM dNTPs, and 12.5 U Taq DNA Polymerase. Cycling
conditions involved 6 cycles of 95°C for 30 sec, 58°C for 1 min, and 68°C for 1.5 min.
Although the construction of these selection templates differs, this allows for the
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maximum amount of DNAs that contain a fully annealed random cassette region as well
as increasing the diversity in the randomized region of the selection template.
The ST2_1437_jcon probe was prepared using a standard NEB PCR protocol for
Taq DNA Polymerase which included 1 ng ST2_1437_jcon DNA, 1X Standard Taq
Reaction Buffer, 200 nM ST2L primer, 200 nM IRD7_ST2R primer, 200 µM dNTPs,
and 1.25 U Taq DNA Polymerase. The ST2_CRP_Ec probe was prepared in the same
fashion as ST2_1437_jcon but 1 ng ST2_CRP_Ec was used instead. Cycling conditions
consisted of 30 cycles of 90°C for 30 sec, 58°C for 30 sec, and 68°C for 1 min. The
ST2_1719_jcon-60 and REPSAis probes were both prepared in the same fashion utilizing
a fusion PCR protocol which involved two consecutive PCR amplifications. The first
fusion PCR step mimics those of the ST2_1437_jcon preparation with 1 ng DNA
template, ST2_1719_jcon-60 or REPSAis (ST2R_1719 and ST2Ls or trP1_ST2L and
ST2R primers), but the samples were amplified for 6 cycles vs 30. After 6 rounds of
amplification, 2 µL of the initial PCR was used to seed the next reaction containing 1X
Standard Taq Reaction Buffer, 200 µM dNTPs, and 1.25 U Taq DNA Polymerase. For
the ST2_1719_jcon-60 probe, 200 nM IRD7_ST2R and 200 nM ST2Ls primers were
used and for REPSAis 200 nM IRD8_trP1_ST2L and 200 nM ST2R primers; both were
amplified for 30 cycles as previously described. The REPSAis probe was used as an
internal standard to determine if DNA-protein interactions are specific vs. nonspecific.
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Table 1. Oligonucleotides used in these studies.
Name
ST2R24
ST2R35

Sequence
CTAGGAATTCGTGCAGAGGTGAATNNNNNNNN
NNNNNNNNNNNNNNNNTTACCATCCCTCCAGA
AGCTTGGAC
CTAGGAATTCGTGCAGAGGTGAATNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNTTAC
CATCCCTCCAGAAGCTTGGAC

Len
gth

Purif.

73

PAGE

84

PAGE

ST2L

CTAGGAATTCGTGCAGAGGTGAAT

24

Desalt

ST2Ls

CTAGGAATTCGTGCAGAGGTGA

22

Desalt

ST2R

GTCCAAGCTTCTGGAGGGATGGTAA

25

Desalt

IRD7_ST2R

/5IRD700/GTCCAAGCTTCTGGAGGGATGGTAA
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Chapter 2.2 Protein Preparation of TTHA1417 and TTHA1719
E. coli BL21 (DE3) competent cells were transformed with the pET-11a plasmid
which contained the TTHA1437 gene of interest. Once transformed, the cells were
inoculated in Super Optimal Broth (SOB) media containing 100 µg/mL ampicillin and
incubated at 37°C/250 rpm. The culture was induced with isopropyl β-D-1thiogalactopyranoside (IPTG; 1 mM final concentration), incubated at 37°C/250 rpm for
4 hours to an OD600 of 0.651 and centrifuged to pellet the bacteria. The bacterial pellet
was resuspended with 2X BEB (40 mM Tris-Cl [pH 7.5], 200 mM NaCl, 0.2 mM EDTA,
2 mM DTT, 1 mM PMSF) and stored at -20°C. Lysozyme was added to the thawed,
resuspended sample to a final concentration of 0.25 µg/µL and incubated for 5 min at
0°C. The cells were then subjected to 5 rounds of sonication (3 W/cm2, 10 sec on/10 sec
off, 0°C) to lyse the cells and centrifuged (10 min, 13,000 rpm, 4°C) to pellet debris.
Following the steps above, the resulting supernatant was subjected to a simple
heat treatment for 15 min at 70°C to purify TTHA1437. This purification method is
extremely simple as the mesothermic E. coli proteins denature at 70°C while the
thermophilic T. thermophilus proteins do not. Once purified, the sample was centrifuged
(15 min, 13,000 rpm, 4°C). The supernatant was diluted in an equal volume of glycerol
and rocked for 1 hour at 4°C to ensure a homogenous TTHA1417 protein stock for
downstream experiments. Purified TTHA1417 was stored at -20°C. The purity of
TTHA1437 was determined using 12% SDS-PAGE and its concentration was quantified
utilizing densitometry with Coomassie and a BSA standard curve (0.5, 1.0, and 2.0
mg/mL).
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TTHA1719 was prepared in a similar manner to TTHA1417, with the following
alterations that allowed optimal protein expression. Due to the rare codon usage of
TTHA1719, RosettaTM 2 (DE3) E. coli competent cells were transformed with the
pTTHA1719 plasmid. 4 samples were then inoculated in 1 mL Lysogeny broth (LB)
media in the presence of 100 µg/mL ampicillin and 35 µg/mL chloramphenicol and
incubated at 37°C/250 rpm. After 1 hour, the two cloudiest cultures were transferred to
50 mL LB media in the presence of 100 µg/mL ampicillin and 35 µg/mL
chloramphenicol, antibiotics required for the maintenance of plasmids. These samples
were incubated at 37°C/250 rpm for 5 hours before 0.5 mL IPTG (1 mM final
concentration) was added to the second sample (sample 1 was used as the uninduced
control). Both samples were incubated at 37°C/250 rpm for 4 hours until the induced
culture had an OD600 of 0.818 and the uninduced an OD600 of
1.23. These were centrifuged (15 min, 4,500 rpm, 4°C), the supernatant decanted,
resuspended in 500 mL 2X BEB, and stored at -20°C until the purification process.
The samples were thawed and resuspended before 30 µL lysozyme (0.25 µg/µL
final concentration) was added and incubated for 10 min at 0°C, mixing once halfway
through. The cells were then subjected to 5 rounds of sonication (2.5 W/cm2, 10 sec
on/30 sec off, 0°C) and centrifuged (15 min, 13,000 rpm, 4°C). The supernatant was
subjected to heat treatment at 70°C for 15 min, mixing halfway through, and centrifuged
(15 min, 13,000 rpm, 4°C). An equal volume of glycerol was added to the supernatant
and rocked (30 min, 4°C) to ensure proper mixing and was stored at -20°C for further
use. The purity of TTHA1719 was determined similarly to TTHA1437 with the
difference being an 18% SDS-PAGE containing 4 M urea. Due to the low molecular
weight of TTHA1719, a traditional 12% SDS-PAGE would be ineffective. The
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concentration of TTHA1437 was determined using a Bradford Protein Assay and the
concentration of TTHA1719 was determined by Quantitative Densitometry with
Coomassie; both of these assays use BSA as a standard. Although some E. coli and
lysozyme proteins are still present, they have not interfered with or affected previously
studied T. thermophilus TFs due to their denatured state and significant dilution of
TTHA1437 and TTHA1719 in future experiments.
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Chapter 2.3 REPSA Selection Method
REPSA selections for TTHA1437 were performed in 20 µL reactions with 4.515
ng (100 fmol) ST2R24 DNA template in 1X CutSmart® Buffer (NEB; 50 mM Potassium
Acetate, 20 mM Tris-acetate, 10 mM Magnesium Acetate, 100 µg/mL BSA, pH 7.9 at
25°C) and 20 µM 3’,5’-cAMP. The first round of REPSA utilized the initial ST2R24
DNA library, while successive REPSA sounds were seeded with 2 ng DNA from the
previous round of REPSA. Each round of REPSA includes three reactions run in tandem:
the DNA control, IISRE control, and the experimental reaction which contains the ligand
of interest (-/-, -/IISRE, and +/IISRE). The DNA and IISRE controls contained 1-3 µL
PDB (20 mM Tris HCl, 100 nM NaCl, 0.1 mM EDTA, 1 mM DTT, 100 µg/mL BSA,
0.1% Tween 20, pH 8.0 at 25°C) respectively, while the experimental reaction was
incubated with 30.9 nM monomeric or 15.45 nM dimeric TTHA1437 protein diluted in
PDB. Once assembled, these reactions were incubated at 55°C for 20 min to facilitate
DNA-ligand interactions and then equilibrated at 37°C for 5 min. After equilibration, the
IISRE control and experimental reactions were treated with 0.8 U FokI and 4 U BpmI
REases for rounds 1-3 and 4-6 and incubated at 37°C for 5 min to cleave any unbound
DNA species. The reactions were then placed on ice to cease endonuclease activity.
Rounds of REPSA for TTHA1437 were also completed in a similar fashion, but without
the addition of cAMP to determine if TTHA1437 does or does not require cAMP for
DNA interactions to occur.
REPSA selections for TTHA1719 were performed in 10 µL reactions with 3.896
ng (75 fmoles) ST2R35 DNA selection template. The differences in REPSA selections
for TTHA1719 include the addition of 1 mM DTT as a reducing agent and 41.6 nM
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monomeric, 20.8 nM dimeric or 10.4 nM tetrameric TTHA1719 protein. Also, 0.8 U
FokI and 4 U BpmI restriction endonucleases were used for rounds 1-2 and 3-11
respectively and incubated for 10 min to allow for maximum cleavage of unbound DNAs.
All other aspects of these selections follow formerly outlined REPSA protocols.
After each round of REPSA, an amplification step is required before continuing
on to another round of selections. Each amplification step utilized three 23 µL reactions
which contained 1X NEB Standard Taq Reaction Buffer (NEB), 200 µM dNTPs, 200 nM
ST2L or ST2Ls primer, 200 nM IRD7_ST2R primer, and 3.5 U Taq DNA Polymerase. 2
µL of the REPSA experimental reaction was added to each before PCR amplification.
The reactions were then amplified for 6, 9, and 12 cycles utilizing the following cycling
conditions: denaturation at 95°C for 30 sec, annealing at 58°C for 1 min, and elongation
at 68°C for 1 min (1.5 min for ST2R35). After PCR amplification, 2 µL from each PCR
reaction were combined with 2 µL 6X Orange Loading Dye (20% wt/vol dextrose, 0.9%
wt/vol Orange G, 1% wt/vol SDS, and 66 mM EDTA).
REPSA reactions and the 6, 9, 12-cycle DNAs were run on a 10% wt/vol Native
PAGE in 0.5X TBE for 10 min at 54V and then 55 min at 108V. Following gel
electrophoresis, the results were imaged and visualized by LI-COR Odyssey Imager and
the DNA concentrations of the amplified species were measured by Qubit 3 Fluorometer
following the manufacturers protocol and reagents.
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Chapter 2.4 Validation of REPSA Selections via Binding Assays
The selected DNA sequences from REPSA were subjected to Restriction
Endonuclease Protection Assay (REPA) to validate the selections. REPA is similar to
REPSA, but with the addition of the REPSAis control DNA and this assay does not
include an amplification step. REPA 10 µL reactions were performed with 1X Cutsmart
Buffer, 2 ng REPSA-selected DNAs (Round 6 for TTHA1437 and Round 11 for
TTHA1719), 2 ng REPSAis control DNA, the respective transcription factor (TTHA1437
or TTHA1719), and the IISRE BpmI (4 U). REPA for TTHA1437 required 20 µM cAMP
and TTHA1719 required 1 mM DTT. Reactions were incubated at 55°C for 20 minutes
and then 37°C for 5 minutes before introducing 4 U BpmI and incubating for another 510 min at 37°C. 2 µL of each REPA reaction were mixed with 2 µL 6X Orange Loading
Dye and run on a 10% wt/vol polyacrylamide (19:1 acryl:bis) gel at 54V for 10 min and
108V for 55 min before visualizing results by IR fluorescence.
Another validation method used was Electrophoretic Mobility Shift Assay
(EMSA). EMSA 5 µL reactions were also performed with 2 ng Round 6 REPSA-selected
DNA, PDB, 20 µM cAMP, and 1 µL TTHA1437 with ten-fold serial dilutions (0, 3.09,
30.9, 309, and 3,090 nM). The reactions were incubated at 55°C for 5 minutes to
equilibrate prior to the addition of TTHA1437. After the addition of protein, the reactions
were incubated at 55°C for 30 minutes to facilitate DNA-protein complex formation. 2
µL 6X Orange Loading Dye without SDS (20% wt/vol dextrose, 0.9% wt/vol Orange G,
and 66 mM EDTA) was added to the EMSA samples prior to gel electrophoresis. The
samples were run on a 0.5X TAE, 10% polyacrylamide gel and run in 0.5X TAE buffer
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for 10 min at 54V and then 55 min at 108V. The results were visualized using the LICOR Odyssey Imager as previously described.
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Chapter 2.5 Binding Assays with Japanese Consensus Probes and E. coli Consensus
Probe
Following REPSA selections for TTHA1437 and validation using REPA and
EMSA, the Japanese consensus DNA for TTHA1437 was used in REPA and BLI.
Similarly, the E. coli CRP consensus DNA was used in EMSA and BLI since TTHA1437
is a supposed orthologous TF to that of E. coli CRP. The REPA followed a similar
protocol as previously described with 10 µL reactions containing 2 ng REPSAis control
DNA, 2 ng ST2_1437_jcon DNA probe, 1X Cutsmart Buffer, and 20 µM cAMP.
Reactions were incubated at 55°C for 20 min and then 37°C for 5 min to equilibrate
reactions before the addition of 0.8 U FokI and a final incubation for 5 min at 37°C.
Results were visualized by IR fluorescence as previously described. The EMSA done
using the E. coli CRP consensus DNA was performed using the same protocol as
previously outlined with the only difference being the DNA template (ST2_CRP_Ec vs
REPSA selected DNAs) and dimeric TTHA1437 protein concentrations of 3.09, 9.27,
27.81, 83.43, and 250.29 nM.
Real-time binding kinetics were determined by biolayer interferometry (BLI)
using biotinylated ST2_1437_jcon DNAs and TTHA1437. Biotinylated DNAs were
prepared by PCR amplification in 50 µL reactions containing 1X Standard Taq Reaction
Buffer, 50 µM dNTPs, 350 nM ST2L primer, 300 nM Bio_ST2R primer, 2 U Taq DNA
Polymerase and 2 ng DNA template (ST2_1437_jcon or ST2_CRP_Ec consensus
DNAs). Cycling conditions consisted of 30 cycles of 95°C for 30 sec, 58°C for 30 sec,
and 68°C for 1 min. The BLI assays were performed with a FortéBio OctetQK instrument
in 96-well microplates using Streptavidin Biosensors (FortéBio) and biotinylated DNAs
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prepared as previously described. Each BLI assay consisted of four lanes by four rows
and each well contained 200 µL reactions which were buffered with BLI 100 Buffer
supplemented with cAMP (20 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, 0.05% Tween
20, 20 µM cAMP, pH 7.7 at 25°C). The loading step consisted of 2 nM biotinylated
DNAs, the background and dissociation steps consisted of 200 µL BLI 100 Buffer w/
cAMP, and the association step contained four concentrations of TTHA1437 (11, 33,
100, and 300 nM), respectively. Binding kinetics were determined using association and
dissociation data and non-linear regression analyses in GraphPad Prism 8.
Unlike the binding assays for TTHA1437 using known DNA templates which
were performed after REPSA selections, the binding assays for TTHA1719 and
ST2_1719_jcon-60 were completed prior to REPSA selections in order to determine not
only if binding occurs but also to determine the optimal protocol conditions to be used in
REPSA selections. The first REPA was followed a similar protocol as previously
described with 10 µL reactions containing 1X Cutmast Buffer, 2 ng REPSAis control
DNA, 2 ng ST2_1719_jcon-60 test DNA, and ten-fold serial dilutions of TTHA1719.
Reactions were incubated at 55°C for 20 min and then at 37°C for 5 min before the
addition of 0.8U FokI and a final incubation at 37°C for 5 min. The results were
visualized using IR fluorescence and were used as a baseline to compare other REPA
experiments in which the reaction conditions were altered.
Because TTHA1719 contains a single cysteine residue, a reducing agent is
needed to avoid disulfide bond formation. Another REPA was performed in the same
fashion as the baseline REPA but with the addition of 2 mM DTT. Four other REPA
experiments were performed to determine if altering the reaction parameters
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would increase or decrease the binding activity of TTHA1719. Two of these REPAs
consisted of altering the binding temperature from 55°C to 37°C and 65°C while in the
other two REPAs the digestion time for FokI was changed from 5 min to 7 min and 9
minutes. All four of the REPA experiments with altered conditions were done under
reducing conditions with 2 mM DTT and results were visualized by IR fluorescence on
the LI-COR Odyssey Imager as previously described.
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RESULTS
Chapter 3.1 Protein Expression, Purification, and Quantitation of TTHA1437 and
TTHA1719
The TTHA1437 protein was expressed in E. coli BL21 (DE3) cells with a pET11a plasmid containing the TTHA1437 gene which yielded significant protein production.
Once expressed, the protein was purified via heat treatment at 70°C and results were
analyzed by 12% SDS-PAGE. Each step of the expression and purification can be
visualized in Figure 5. TTHA1437 can be observed as a strong band with a molecular
weight of about 24 kDa, which is consistent with the literature.26 When comparing the
soluble and purified phases, it is estimated that TTHA1437 is greater than 90% pure
(Figure 5, lane 6). Although there are a few denatured E. coli proteins present (lane 6),
but they are at such low concentrations that they should not affect any of our
experimental results which has been previously observed for other Thermus thermophilus
HB8 TFs studied in our laboratory.32,33,35,36 The identities of these remaining soluble E.
coli proteins have yet to be determined. TTHA1437 protein quantitation was done using a
Bradford Protein Assay and its concentration was determined to be 30.9 µM (Figure 6).
Similarly, TTHA1719 was expressed in Rosetta 2 E. coli (DE3) cells with a pET11a plasmid containing the TTHA1719 gene; TTHA1719 was expressed in Rosetta 2 due
to its rare codon usage. The results were analyzed by 18% SDS-PAGE with 4 M urea and
the results can be visualized in Figure 7 with TTHA1719 as a strong band in lane 4.
TTHA1719 was determined to be greater than 60% pure which is a lower purity than

29

normally observed for other T. thermophilus HB8 TFs that have been previously studied.
The concentration of TTHA1719 was determined using Quantitative Densitometry with
Coomassie and was calculated to be 41.6 µM (Figure 8).
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Figure 5. Expression and purification of TTHA1437 protein. Shown is a
12% SDS-PAGE gel stained with Coomassie Blue G-250 on which
samples from protein expression and purification steps were analyzed.
Lanes were loaded with samples of protein ladder (lad), logarithmic
growth phase (log), induced and post-incubation (ind), sample after
freeze and thaw cycle (F/T), soluble proteins following sonication (sol),
and purified TTHA1437 following high temperature purification.
Molecular weights of the protein ladder are indicated on the left of the
figure and the protein band corresponding to TTHA1437 is indicated on
the right.
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Figure 6. Quantitation of TTHA1437 using Bradford Protein Assay.
Shown is the Bradford standard curve which was created by using bovine
serum albumin (BSA) as the known standard. After the standard curve
was established, the concentration of TTHA1437 was calculated using its
molecular weight. The final concentration of TTHA1437 is estimated to
be 30.9 µM.
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120

Figure 7. Expression and purification of TTHA1719 protein. Shown is
an 18% SDS-PAGE w/ 4 M urea gel stained with Coomassie Blue G-250
on which samples from protein expression and purification steps were
analyzed. Lanes were loaded with samples of protein ladder (lad),
logarithmic growth phase (log), induced and post-incubation (ind),
soluble proteins following sonication (sol), and purified TTHA1719
following high temperature purification. Molecular weights of the
protein ladder are indicated on the left of the figure and the protein band
corresponding to TTHA1719 is indicated on the right.
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BSA

Figure 8. Quantitation of TTHA1719 using Quantitative Densitometry
with Coomassie. This quantitation method also uses BSA as a standard to
create a linear relationship, but the proteins are quantified by intensity
rather than absorbance. Shown is the protein ladder (lad), BSA standards
(left to right: 500 ng and 1000 ng protein), and TTHA1719. The final
concentration of TTHA1719 was estimated to be 41.6 µM.
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Chapter 3.2 REPSA Results for TTHA1437 and TTHA1719
REPSA was used to select the TTHA1437 and TTHA1719 binding sites from a
pool of 100 fmoles or 75 fmoles DNA selection template molecules, respectively. The
ST2R24 selection template was used in REPSA selections for TTHA1437, while the
ST2R35 selection template was used for TTHA1719 REPSA selections. The ST2R24
template has previously been used to successfully identify TFs in other studies, but this is
the first time that the ST2R35 template has been used in our laboratory for REPSA
selections32,33,35,36. Here, TTHA1437 was subjected to two different REPSA selections in
which one was run in the presence of 2 mM cAMP while the other was not. For
TTHA1437 REPSA selections containing cAMP, six rounds were performed until the
emergence of DNA resistant to IISRE cleavage (Figure 9, Round 6). In Round 6, the
ST2R24 template DNA control (-/-) was uncut in the absence of BpmI and TTHA1437;
the template DNA in the cleavage control (-/B) was completely cut with the presence of
BpmI and the absence of TTA1437; the template DNA in the experimental reaction (+/B)
was ~30% uncut in the presence of BpmI and TTHA1437 which represents the REPSAselected sequences. Similarly, TTHA1437 REPSA selections were done without the
addition of cAMP and were performed for nine rounds until IISRE cleavage resistance
was observed in the cleavage control and experimental reaction (Figure 10, Round 9,
lanes 2 and 3).
TTHA1719 REPSA selections were performed for ten rounds using the ST2R35
DNA template under reducing conditions with 1 mM DTT until ~10% of the template
was uncut (Figure 11, Round 10, lane 3) and the internally primed asterisk species was
greater than 40% (Figure 11, Round 10, lane 1). It is important to note that initial rounds

35

of REPSA utilized the IISRE FokI until FokI resistant DNAs emerged in the cleavage
control at which point subsequent REPSA rounds used the IISRE BpmI to cleave the
DNA selection templates. Typically, REPSA results are validated by REPA and EMSA
before sequencing, but since the REPSA-selected sequences were not validated, the
selections were not sequenced.

36

1437/RE

Figure 9. REPSA selection of TTHA1437-binding sequences with
cAMP. Shown are IR fluorescence images of restriction endonuclease
cleavage-protection assays for Round 1 and Round 6 of REPSA
selections with 31 nM TTHA1437 protein. Reactions in lane 1 represents
the DNA control (-/-), lane 2 being the cleavage control containing the
DNA template and IISRE (-/F or -/B to represent FokI andBpmI IISREs
respectively), and lane 3 is the experimental reaction containing DNA
template, IISRE, and TTHA1437 (+/F or +/B). Band designations: (T)
intact ST2R24 selection template, (X) cleaved ST2R24 selection
template, and (P) IRD7_ST2R primer.
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Figure 10. REPSA selection of TTHA1437-binding sequences without
cAMP. Shown are IR fluorescence images of restriction endonuclease
cleavage-protection assays for Round 1 and Round 9 of REPSA
selections with 31 nM TTHA1437 protein. Reactions in lane 1 represents
the DNA control (-/-), lane 2 being the cleavage control containing the
DNA template and IISRE (-/F or -/B to represent FokI andBpmI IISREs
respectively), and lane 3 is the experimental reaction containing DNA
template, IISRE, and TTHA1437 (+/F or +/B). Band designations: (T)
intact ST2R24 selection template, (A) internally primedasterisk species,
(X) cleaved ST2R24 selection template, and (P) IRD7_ST2R primer.
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Figure 11. REPSA selection of TTHA1719-binding sequences. Shown are
IR fluorescence images of restriction endonuclease cleavage-protection
assays for Round 1 and Round 10 of REPSA selections with 42 nM
TTHA1719 protein. Reactions in lane 1 represents the DNA control (-/-),
lane 2 being the cleavage control containing the DNA template and IISRE
(-/F or -/B to represent FokI and BpmI IISREs respectively), and lane 3 is
the experimental reaction containing DNA template, IISRE, and
TTHA1437 (+/F or +/B). Band designations: (T) intact ST2R35 selection
template, (A) internally primed asterisk species, (X) cleaved ST2R35
selection template, and (P) IRD7_ST2R primer.
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Chapter 3.3 Validation of REPSA Results via REPA and EMSA
Following REPSA selections for TTHA1437 and TTHA1719, the selected DNA
species were attempted to be validated using both REPA and EMSA, but both were
unsuccessful. REPA was performed to determinewhether specific or nonspecific DNAbinding interactions occurred between TTHA1437and the ST2R24 template (Figure
12A) or TTHA1719 and the ST2R35 template (Figure 12B). REPA utilizes a fluorescent
green-labeled DNA probe, REPSAis, which contains adefined DNA template, the
REPSA-selected DNAs (Round 6 or Round 10, respectively),and the respective IISRE.
Since no REPSA-selected DNAs were observed for TTHA1437 without cAMP, no
REPA was performed. The REPA results for TTHA1437 indicate nonspecific binding
due to TTHA1437-REPSAis binding interactions.
Contrarily, the REPA results for TTHA1719 do not indicate any binding interactions at
all, specific or nonspecific, since both the cleavage control and experimental reactions do
not show any protein-DNA interactions.
In addition to REPA, EMSA was used to validate REPSA selections which would
typically quantify the affinity of the TF for the selected DNAs. Ten-fold dilutions of
TTHA1437 and TTHA1719 with their respective selected DNAs did now show any
protein-DNA complex formation which indicates that the protein is not binding to any or
not the majority of the DNA sequences (Figures 13A and 13B).
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Figure 12. Attempt to validate TTHA1437 and TTHA1719 DNA-binding
sequences with REPA. (A) Shown is an IR fluorescence image of restriction
endonuclease protection assay with ST2R24 DNAs selected from Round 6 of
REPSA for TTHA1437 with cAMP. (B) Shown is an IR fluorescence image of
REPA with ST2R35 DNAs selected from Round 10 of REPSA for TTHA1719.
The presence(+) or absence (-) of protein (TTHA1437 or TTHA1719
respectively) and IISRE BpmI (B) are denoted above each lane. Band
designations: (T) intact and (X) cleaved IRD7-labeled ST2R24 or ST2R35
selection template (red) and IRD8- labeled REPSAis control DNA (green).
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Figure 13. Attempt to validate TTHA1437 and TTHA1719 DNA-binding sequences with EMSA. (A) Shown is an IR
fluorescence image of electrophoretic mobility shift assay with ST2R24 DNAs selected from Round 6 of REPSA for TTHA1437
with cAMP incubated with increasing concentrations of TTHA1437 protein (from left to right: 0, 3.09, 30.9 309 and 3,090 nM
TTHA1437). (B) Shown is an IR fluorescence image of EMSA with ST2R35 DNAs selected from Round 10 of REPSA for
TTHA1719 incubated with increasing concentrations of TTHA1719 protein (from left to right: 0,4.16, 41.6, 416, and 4,160 nM
TTHA1719). (C) indicates the DNA control in the absence of protein.
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Chapter 3.4 Analysis of Proposed and Known Consensus DNAs with Binding Assays
Prior to REPSA selections with TTHA1719, the proposed consensus sequence for
its binding site was subjected to multiple REPAs to determine the optimal protocol
conditions which were later used in REPSA selections.28 These assays were done prior to
REPSA selections due to TTHA1719’s low molecular weight and its tetrameric binding
activity. The initial REPA was performed under standard and unaltered conditions to
create baseline data to compare altered REPA experiments to (Figure 14). The REPA
experiments with altered reaction conditions are as follows: addition of a reducing agent
(1 mM DTT), increased digestion time for IISRE (7 and 9 min), and altered incubation
temperature for TF binding (37°C or 65°C); Figures 15-19. The results of these
preliminary experiments demonstrated that the reaction conditions to be used in REPSA
selections for TTHA1719 were the addition of 1 mM DTT, 9 min digestion time with
IISRE FokI or BpmI, and an incubation temperature of 55°C to allow protein-DNA
complex formation.
Additionally, EMSA and BLI were performed for the E. coli CRP consensus
sequence with TTHA1437 following REPSA selections. These assays were done after
REPSA selections and validation since the REPA results showed nonspecific binding and
the EMSA results did not show any protein-DNA complex formation (Figure 20). The E.
coli CRP consensus DNA was chosen for these assays since TTHA1437 belongs to the
CRP/FNR class of TFs in T. thermophilus HB8 and is speculated to be homologous to the
E. coli CRP in function and/or structure.20,22 Unfortunately, the results of EMSA with the
CRP consensus sequence and TTHA1437 did not show any protein-DNA complex
formation. The BLI results also showed no binding activity when the real-time kinetics
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were observed with TTHA1437 concentrations of 11, 33, 100 and 300 nM (Figure 21).
No BLI was done with our control DNA, REPSAis, since there BLI results between
TTHA1437 and the E. coli CRP consensus DNA were ambiguous.

44

Figure 14. Baseline REPA with proposed consensus and TTHA1719. Shown
is an IR fluorescence image of restriction endonuclease protection assay with
ST2_1719_jcon-60 and TTHA1719. (DC) denotes DNA control, (CC)
denotes the cleavage control. Lanes 2-6 contain 0.4 U IISRE FokI.
TTHA1719 concentrations from left to right are 4.16, 41.6, 416, and 4160
nM. Band designations: (T) intact and (X) cleaved IRD7-labeled
ST2_1719_jcon-60 DNA template (red) and IRD8-labeled REPSAis control
DNA (green).
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Figure 15. Experimental REPA with a reducing agent. Shown is an IR
fluorescence image of restriction endonuclease protection assay with
ST2_1719_jcon-60, TTHA1719, and 1 mM DTT. (DC) denotes DNA
control, (CC) denotes the cleavage control. Lanes 2-6 contain 0.4 U IISRE
FokI. TTHA1719 concentrations from left to right are 4.16, 41.6, 416, and
4160 nM. Band designations: (T) intact and (X) cleaved IRD7-labeled
ST2_1719_jcon-60 DNA template (red) and IRD8-labeled REPSAis control
DNA (green).
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Figure 16. Experimental REPA with 7 min IISRE digestion time.
Shown is an IR fluorescence image of restriction endonuclease
protection assay with ST2_1719_jcon-60, TTHA1719, and 1 mM DTT.
(DC) denotes DNA control, (CC) denotes the cleavage control. Lanes 26 contain 0.4 U IISRE FokI. TTHA1719 concentrations from left to
right are 4.16, 41.6, 416, and 4160 nM. Band designations: (T) intact
and (X) cleaved IRD7-labeled ST2_1719_jcon-60 DNA template (red)
and IRD8-labeled REPSAis control DNA (green).
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Figure 17. Experimental REPA with 9 min IISRE digestion time. Shown is an
IR fluorescence image of restriction endonuclease protection assay with
ST2_1719_jcon-60, TTHA1719, and 1 mM DTT. (DC) denotes DNA control,
(CC) denotes the cleavage control. Lanes 2-6 contain 0.4 U IISRE FokI.
TTHA1719 concentrations from left to right are 4.16, 41.6, 416, and 4160 nM.
Band designations: (T) intact and (X) cleaved IRD7-labeled ST2_1719_jcon60 DNA template (red) and IRD8-labeled REPSAis control DNA (green).
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Figure 18. Experimental REPA with 37°C binding temperature. Shown is
an IR fluorescence image of restriction endonuclease protection assay with
ST2_1719_jcon-60, TTHA1719, and 1 mM DTT. (DC) denotes DNA
control, (CC) denotes the cleavage control. Lanes 2-6 contain 0.4 U IISRE
FokI. TTHA1719 concentrations from left to right are 4.16, 41.6, 416, and
4160 nM. Band designations: (T) intact and (X) cleaved IRD7-labeled
ST2_1719_jcon-60 DNA template (red) and IRD8-labeled REPSAis
control DNA (green).
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Figure 19. Experimental REPA with 65°C binding temperature. Shown
is an IR fluorescence image of restriction endonuclease protection assay
with ST2_1719_jcon-60, TTHA1719, and 1 mM DTT. (DC) denotes
DNA control, (CC) denotes the cleavage control. Lanes 2-6 contain 0.4
U IISRE FokI. TTHA1719 concentrations from left to right are 4.16,
41.6, 416, and 4160 nM. Band designations: (T) intact and (X) cleaved
IRD7-labeled ST2_1719_jcon-60 DNA template (red) and IRD8labeled REPSAis control DNA (green).
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Figure 20. Investigation of TTHA1437-CRP consensus interactions
with EMSA. Shown is an IR fluorescence image of electrophoretic
mobility shift assay with IRD7-labeled ST2_CRP_Ec DNA and
TTHA1437. Thereactions were run with 2 mM cAMP and the running
buffer was supplemented with cAMP to a final concentration of 2 mM.
No protein-DNA complex formation was observed.

Figure 21. BLI raw data plot of TTHA1719-CRP consensus binding.
Shown is the biolayer interferometry data between TTHA1719 and the
E. coli consensus DNA. Binding kinetics were observed over 1200 sec
with TTHA1437 concentrations of 11, 33, 100, and 300 nM. The BLI
100 buffer was supplemented with cAMP to a final concentration of 2
mM. Since no association or dissociation steps were observed, no KD
could be calculated and the results of this BLI were deemed ambiguous.
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DISCUSSION
In these studies, the combinatorial selection method Restriction Endonuclease
Protection, Selection, and Amplification (REPSA), was used to determine if DNAbinding interactions occurred between our ST2R24 selection template and TTHA1417 as
well as the ST2R35 selection template and TTHA1719. Although TTHA1417 showed a
~30% protected DNA pool and TTHA1719 showed ~10% protected DNA pool when the
results were verified using Restriction Endonuclease Protection Assay (REPA) and
Electrophoretic Mobility Shift Assay (EMSA) the selected species were either deemed as
nonspecific binding or not able to be validated using these methods. As mentioned
previously, using EMSA to validate TTHA1437-DNA interactions was not a preferred
method due to its proposed need for the effector molecule cAMP.
The preliminary REPA binding assays with the proposed consensus DNA for
TTHA1719 proved to be promising with the amount of protected DNA species, but this
was only used to establish optimal protocol conditions for REPSA selections with
TTHA1719. If time allowed, it would have been beneficial to run other binding assays
such as EMSA to determine the percentage of DNA-protein complexes as well as
Biolayer Interferometry (BLI) to ascertain the binding kinetics.
Although our REPSA method has worked for previously studied Thermus
thermophilus HB8 transcription factors in our laboratory, REPSA was not successful in
identifying the DNA-binding consensus sequence for both TTHA1417 and TTHA1719.
This demonstrates that this method is not viable for identifying and characterizing all TFs
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in T. thermophilus HB8. As previously stated, TTHA1417 belongs to the CRP/FNR
family of activators in this organism and has been proposed to be a cAMP receptor
protein with possible homology to E. coli CRP. It is possible that TTHA1437 is not a
local regulator, but a global regulator like that of E. coli CRP. If this is the case, the
REPSA method would not be able to identify a consensus DNA-binding sequence for
TTHA1437 due to many factors such as co-regulation, dual regulation and a possible
DNA-binding domain that is not highly specific.
TTHA1719 is a copper-sensing transcriptional repressor (CsoR) which is
speculated to only regulate a single operon, the copper-sensitive operon. Using REPAS to
identify a TF which regulates only a single operon would be extremely difficult since its
DNA-binding sequence would be extremely specific to that transcription factor. In the
past, TFs characterized by REPSA have traditionally been thought to regulate more than
a single operon, with most potentially regulating multiple. Although REPSA was unable
to identify and characterize the DNA-binding sites of TTHA1437 and TTHA1719 and
their potential biological functions, these studies show that the REPSA method can in fact
not characterize all Thermus thermophilus HB8 transcription factors.

53

APPENDIX: FUTURE DIRECTIONS
Future directions include further investigation of the TTHA1719 proposed
consensus sequence as well as the investigation of the asterisk species found in REPSA
selections with both ST2R24 and TTHA1437 as well as ST2R35 and TTHA1719. The
asterisk species has rarely been observed and its sequence is highly unknown. It is a
truncated DNA species that is caused by internal priming in the randomized region of the
selection template. Interestingly, the asterisk species became visible and amplified more
rapidly with the ST2R35 template than the ST2R24 template, so it is quite possible that
the length of the internal randomized region plays a role in asterisk species formation.
Sequencing these rare DNA species would determine if the asterisk species from different
REPSA selections and selection templates would reveal different sequences.
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